Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

SHARE-BASED COMPENSATION

v3.22.1
SHARE-BASED COMPENSATION
3 Months Ended
Mar. 31, 2022
Share-Based Compensation [Abstract]  
SHARE-BASED COMPENSATION

8.SHARE-BASED COMPENSATION

The Company’s share-based compensation plans includes stock options and Restricted Share Units (“RSU”). The Company has reserved up to 15% of the issued and outstanding Common Shares for the granting of stock options and RSUs to eligible Employees, Officers, Directors and external consultants.

Common shares outstanding, March 31, 2022

111,202,690

Share-based compensation available for issuance: 15%

16,680,404

Stock options outstanding, March 31, 2022

(4,830,628

)

RSU outstanding, March 31, 2022

(1,730,605

)

Share-based compensation available for future grants

10,119,171

(a)Stock Options

The Company granted stock options to acquire common stock through our stock option plan of which the following are outstanding as March 31:

2022

2021

Stock

Options

Weighted Average Exercise Price

Stock

Options

Weighted Average Exercise Price

Balance, January 1

$

5,257,089

$

1.73

$

2,923,770

$

1.76

Granted

-

-

1,801,262

2.21

Forfeited

(426,461

)

2.38

(10,663

)

2.76

Expired

-

-

(9,810

)

3.61

Exercised

-

-

(19,568

)

0.73

Balance, March 31

$

4,830,628

$

1.73

$

4,685,021

$

1.93

(b)Restricted Share Units

The Company granted RSUs to Officers and Directors through our incentive share award plan. Grants of RSUs to Directors vest either immediately or on the date of the next Annual General Meeting. Grants of RSUs to Officers vest over a four-year period. The following RSUs are outstanding at March 31:

2022

2021

Balance at Jan 1

1,581,607

-

Granted

148,998

1,527,860

Released

-

-

Cancelled

-

-

Balance, March 31

1,730,605

1,527,860

(c)Stock-Based Compensation

The following table shows the stock-based compensation expense.

Three Months Ended

March 31, 2022

March 31, 2021

$

$

Stock options

212

316

RSUs

209

342

G&A - Stock options & RSUs

421

658

R&D - Stock options

172

111

Share-based compensation expense

593

769